MedPath

Comparison of Zimmer Maxera Acetabular System to the Allofit Cup with Roentgen Stereophotogrammetric Analysis (RSA) in Total Hip Arhtroplasty

Completed
Conditions
Hip osteoarthritis
hip wear
10023213
Registration Number
NL-OMON53013
Lead Sponsor
Reinier Haga Orthopedisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
54
Inclusion Criteria

1. Male and non-pregnant females : <= 75 years
2. Patients with a Quetelet index (QI=weight in (kilogram)/ square length
(meters)) < 35.
3. Patients requiring primary THR, suitable for the use of the Maxera Cup
and Allofit Cup.
4. The patient is diagnosed with osteoarthritis (OA) or avascular necrosis.
5. The individual is physically and mentally willing and able to comply with
postoperative functional evaluation and able to participate in an appropriate
rehabilitation schedule.
6. ASA classification score I-III.
7. Patients who signed the Ethics Committee approved specific Informed Consent
Form prior to surgery.

Exclusion Criteria

1. Patients who had a THA on contralateral side more than 6 months ago and the
rehabilitation period outcome is considered unsatisfactory or not good.
(Patients with contra-lateral THA >6 months ago with good outcome (Harris Hip
Score >85) can be included in the study).
2. Patients who had a THA on contralateral side less than 6 months ago.
3. Patients with a major surgical procedure during the 12 weeks before the
study-related operation.
4. Dutch language not mastered
5. The patient is unwilling to cooperate with the study
6. The patient is pregnant or desired to be pregnant after surgery or is using
inadequate birth control
7. Recent Myocardial infarct or CVA (<3 months).
8. Mentally disabled patients.
9. Patients with a Quetelet index (QI=weight in (kilogram)/ square length
(meters)) > 35.
10. Any active infection
11. Current malignancy
12. Uncontrolled hypertension
13. Known history of alcohol or drugs abuse.
14. ASA IV-V

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath